Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HemaTechnologies is a private U.S. medical device and diagnostics company that develops, manufactures, and markets clinical laboratory instruments focused primarily on erythrocyte sedimentation rate (ESR) testing. Its flagship products include the ESR STAT 6 and ESR STAT PLUS automated sed-rate analyzers, which are designed for rapid ESR measurement from small EDTA whole-blood samples and integration into hospital laboratory workflows. The company also has been associated with the Hematek 3000 blood smear staining system and sells related consumables and controls. HemaTechnologies appears to serve hospital and clinical laboratory customers rather than developing therapeutic drug assets, making it a commercial-stage diagnostics instrumentation company rather than a biotech therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HemaTechnologies.